Table S4 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
crossref（2023）
摘要
Table S4 shows descriptive statistics of ASTX660 pharmacokinetic parameters per dose level across cycles and days: pharmacokinetic population
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要